One Stop Shop for All Your Market Research Reports

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027

Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases. Market Analysis and Insights: Global Cell and Gene Therapy Market The global Cell and Gene Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy market. Global Cell and Gene Therapy Scope and Market Size Cell and Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Rare Diseases Oncology Hematology Cardiovascular Ophthalmology Neurology Other Therapeutic Classes Segment by Application Pharmaceutical and Biotechnology Companies Research and Academic Institutions Contract Research Organizations (CROs) Hospital Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Amgen Inc. bluebird bio, Inc. Dendreon Pharmaceuticals LLC. Fibrocell Science, Inc. Human Stem Cells Institute Kite Pharma, Inc. Kolon TissueGene, Inc. Novartis AG Orchard Therapeutics plc. Organogenesis Holdings Inc. Pfizer, Inc. RENOVA THERAPEUTICS Shanghai Sunway Biotech Co., Ltd., Sibiono GeneTech Co. Ltd., Spark Therapeutics, Inc. Vericel Corporation ViroMed Co., Ltd.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Rare Diseases 1.2.3 Oncology 1.2.4 Hematology 1.2.5 Cardiovascular 1.2.6 Ophthalmology 1.2.7 Neurology 1.2.8 Other Therapeutic Classes 1.3 Market by Application
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 783618
  • Healthcare
Published on 29-Nov
Number of Pages 119
Publisher Name QY Research
Editor Rating